PDA Publishes Results of Transportation Validation Benchmarking Survey
Recommendation
Thursday, 2 October 2025 9 .30 - 16.45 h
Register now for ECA's GMP Newsletter
In June 2025, the Parenteral Drug Association (PDA) published the results of its 2025 Transportation Validation Benchmarking Survey.
The PDA writes: "This survey aimed to gather industry benchmarking data on transportation qualification strategies within the pharmaceutical and biopharmaceutical industry. Specifically, the goal was to examine the application of simulated data to better understand how transportation conditions impact drug product quality, emphasizing the importance of ensuring product quality during transit. The survey focused on evaluating transportation through simulated environments versus real-world qualification of temperature-controlled shipping systems. [...]
To contextualize responses, the survey included general demographic questions and was structured into product-specific, supply-chain-focused, and regulatory strategy-driven categories. The manufacturers of small molecule medicines and oral dosage forms were not a target audience for this survey."
The full 40-page report (PDA Item No. 8363) is available as a PDF download on the PDA website. The price is $180 for members and $325 for nonmembers. Premium members can request a free copy until 17 July 2025.
Related GMP News
14.07.2025New Swissmedic Technical Interpretation on Returns of Medicinal Products
14.07.2025Two new GDP Non-Compliance Reports from Austria and Ireland published in the EudraGMDP database
14.07.2025Reminder: Participate in the GDP Implementation Survey until 31 July 2025
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms